Psyence Biomedical PBM Cash Flow Statement (2023-2026)

NASDAQ PBM
$4.66 +0.42 (+10.07%)
As of: Oct 21, 2026 · 10:20 AM EDT
Reported Financials

Psyence Biomedical Quarterly Cash Flow Statement

Periods 5 quarters
Latest Mar 2026

Psyence Biomedical cash flow statement data for the quarter ended Mar 2026. This cash flow statement covers 5 quarters of results from Mar 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2023 Sep2023 Sep2024 Sep2025 Mar2026
Operating Activities
Net Income -0.31M0.14M-0.75M
Depreciation and DepletionDep. & Depletion 0.00M0.00M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.00M0.00M
Other non-cash itemsOther Non-Cash 0.00M0.06M
Additional items
Ending Cash Balance 1.33M0.61M7.44M

Psyence Biomedical Cash Flow Statement API

Pull Psyence Biomedical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PBM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY